Deaths described in malpractice lawsuits, a separate disciplinary complaint and limited public access to pending physician investigations have sharpened a California debate over cosmetic-surgery oversight. The public record supports serious questions about transparency, but not a blanket verdict against every surgery chain.
KFF Health News and NBC News examined allegations involving multistate cosmetic-surgery businesses. Their reporting prompted the American Society of Plastic Surgeons to urge prospective patients to research the surgeon, facility and risks before liposuction, fat transfer or other elective procedures.
The warning is not a finding that low prices themselves cause injuries. The underlying evidence consists of lawsuits, court records, a state administrative complaint and interviews. Some companies have disputed allegations, some lawsuits have been dismissed, and other cases have ended in confidential settlements.
Three Deaths Were Alleged in California Lawsuits
Malpractice lawsuits filed by three families said three patients of California plastic surgeon Heidi Regenass died within a few months after liposuction and fat-transfer operations. Regenass is board-certified. She denied negligence and denied that her actions caused the deaths, according to KFF Health News. One case was settled in 2024 and two were pending when KFF published its report.
Ste'Aira Ballard, whose mother Tamala Smith died in 2023 after Regenass operated on her, filed a complaint with the Medical Board of California in early 2025. Ballard told KFF that a state investigator interviewed her that June. The existence and status of such a review are generally not visible to the public while it remains at the complaint stage.
These details require legal precision. A lawsuit contains allegations, not a judgment that negligence occurred. A settlement does not by itself establish liability. The deaths are part of the reason for scrutiny, but the surgeon's denials and the procedural status of the cases belong in the same account.
A Separate Board Case Became Public
On February 9, 2026, the California Medical Board filed an administrative complaint against Regenass involving a different patient. That action was unrelated to the three deaths described in the lawsuits. It alleged repeated negligent acts in the care of a 49-year-old woman who underwent abdominal and arm liposuction with fat transfer to the buttocks in July 2022.
The board alleged that Regenass did not document an appropriate physical examination before surgery and did not maintain adequate and accurate records. It requested an administrative hearing. KFF reported that no hearing date had been set and that lawyers for Regenass did not respond to its request for comment on those allegations.
An administrative accusation is a formal public action, but it is not a final disciplinary decision. The distinction between a filed accusation, a pending investigation and a completed case is central to fair reporting and to what a patient can discover before choosing a surgeon.
California's Complaint Process Leaves a Blind Spot
TJ Watkins, a public member of the state medical board, argued that the public should be alerted when a doctor is being investigated over alleged misconduct. A board spokesperson told KFF that California law does not authorize the board to post complaint information unless it obtains an emergency suspension or files a formal administrative complaint. Changing that rule would require action by the Legislature and governor.
The gap extends beyond one physician. KFF reported that there is no federal public database showing cosmetic-surgery companies' safety records, staffing standards or rates of serious complications. State medical-board complaints can also remain confidential for years. Patients may therefore see a license and advertising but not a complete, comparable record for the business organizing the procedure.
That absence should not be filled with unsupported numbers. The available reporting does not establish a California-wide surge in injuries, a standard daily procedure count for chain surgeons or a causal link between private-equity ownership and an individual complication. It establishes that relevant allegations and investigations can be difficult for patients to see.
Verification Helps, but It Cannot Replace Oversight
The American Society of Plastic Surgeons advises patients to verify certification by the American Board of Plastic Surgery and to ask whether the operation will take place in an accredited, state-licensed or Medicare-certified facility. It also recommends asking whether the surgeon has hospital privileges for the specific procedure. These checks can reveal training and facility standards; they cannot guarantee an outcome.
Prospective patients should also receive a procedure-specific explanation of risks, alternatives, recovery and follow-up. They can ask who will perform the operation, who will provide anesthesia, how complications are handled after hours and where they would be transferred in an emergency. A sales consultation and a surgical consent discussion are not interchangeable.
The oversight failure is not that every clinic is a hidden catastrophe. It is that patients cannot consistently compare the records that would help them judge risk. Credential checks place some responsibility on consumers, but they do not solve confidential complaints, fragmented company data or delayed disciplinary findings. Transparent, timely and legally qualified records would protect patients better than either glossy advertising or indiscriminate condemnation.